NTLA - Intellia Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.29
DETAILS
HIGH:
$49.00
LOW:
$13.00
MEDIAN:
$25.00
CONSENSUS:
$26.29
UPSIDE:
108.65%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 67.7 | 57.9 | 36.3 | 52.1 | 33.1 | 58.0 | 43.1 | 30.4 | 26.1 | 16.5 | 6.0 | 0 |
| Cost of Revenue | 15.9 | 10.3 | 9.0 | 7.6 | 6.9 | 150.4 | 108.4 | 89.1 | 67.6 | 31.8 | 11.2 | 1.7 |
| Gross Profit | 51.7 | 47.6 | 27.3 | 44.5 | 26.2 | (92.4) | (65.3) | (58.7) | (41.5) | (15.4) | (5.1) | (1.7) |
| Operating Expenses | ||||||||||||
| R&D Expenses | 388.9 | 466.3 | 435.1 | 420.0 | 229.8 | 150.4 | 108.4 | 89.1 | 67.6 | 31.8 | 11.2 | 10.7 |
| SG&A Expenses | 119.8 | 125.8 | 116.5 | 90.3 | 71.1 | 44.2 | 41.1 | 32.2 | 28.0 | 16.8 | 8.3 | 3.6 |
| Other Expenses | (15.9) | (10.3) | (9.0) | (7.6) | (6.9) | (150.4) | (108.4) | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 492.7 | 581.9 | 542.6 | 502.7 | 294.0 | 44.2 | 41.1 | 121.3 | 95.7 | 48.6 | 19.5 | 12.7 |
| Operating Income | ||||||||||||
| Operating Income | (441.0) | (534.3) | (515.3) | (458.2) | (267.9) | (136.6) | (106.4) | (90.9) | (69.6) | (32.2) | (13.4) | (5.2) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 29.2 | 47.8 | 49.8 | 8.5 | 1.3 | 2.4 | 6.8 | 5.5 | 2.0 | 0.5 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | (396.8) | (524.0) | (506.3) | (450.6) | (261.0) | (130.3) | (100.8) | (86.4) | (66.6) | (31.1) | (13.1) | (9.5) |
| EBIT | (412.7) | (534.3) | (515.3) | (458.2) | (267.9) | (136.6) | (106.4) | (90.9) | (69.6) | (32.2) | (13.4) | (9.5) |
| Income Before Tax | (412.7) | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (99.5) | (85.3) | (67.5) | (31.6) | (13.4) | (14.3) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.0) | 0 |
| Net Income | (412.7) | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (99.5) | (85.3) | (67.5) | (31.6) | (12.4) | (14.3) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 | -1.96 | -1.98 | -1.88 | -0.91 | -0.70 | -1.39 |
| EPS (Diluted) | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 | -1.96 | -1.98 | -1.88 | -0.91 | -0.70 | -1.39 |
| Shares Outstanding | 108.4 | 98.8 | 88.8 | 77.0 | 70.9 | 56.0 | 47.2 | 43.1 | 36.0 | 34.6 | 17.7 | 10.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 155.5 | 189.2 | 226.7 | 523.5 | 123.4 | 160.0 | 57.2 | 58.9 | 340.7 | 273.1 |
| Short-Term Investments | 294.4 | 412.3 | 685.5 | 669.1 | 625.3 | 437.4 | 222.5 | 255.2 | 0 | 0 |
| Net Receivables | 9.5 | 8.5 | 36.5 | 3.8 | 2.0 | 2.1 | 4.6 | 7.5 | 10.5 | 6.5 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 68.4 | 29.8 | 49.7 | 20.4 | 0 | 0 | 0 | 3.4 | 3.7 | 1.8 |
| Total Current Assets | 527.7 | 639.9 | 998.3 | 1,216.8 | 769.3 | 616.5 | 289.5 | 325.0 | 354.8 | 281.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 123.6 | 246.7 | 148.1 | 161.0 | 100.1 | 55.1 | 37.1 | 17.1 | 15.3 | 10.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 35.5 | 44.3 | 154.5 | 142.3 | 425.1 | 4.7 | 4.7 | 0 | 0 | 0 |
| Other Non-Current Assets | 155.2 | 260.2 | 0 | 0 | 0 | 0 | 2.9 | 5.3 | 6.1 | 7.0 |
| Total Non-Current Assets | 314.4 | 551.2 | 302.6 | 303.3 | 525.2 | 59.8 | 44.8 | 22.3 | 21.4 | 17.7 |
| Total Assets | 842.1 | 1,191.0 | 1,301.0 | 1,520.1 | 1,294.5 | 676.3 | 334.3 | 347.3 | 376.2 | 299.0 |
| Current Liabilities | ||||||||||
| Account Payables | 20.3 | 14.6 | 7.5 | 5.2 | 9.7 | 10.5 | 3.9 | 2.7 | 2.2 | 4.7 |
| Short-Term Debt | 26.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 7.3 | 20.7 | 22.1 | 43.8 | 63.8 | 22.5 | 12.7 | 27.1 | 21.2 | 20.2 |
| Other Current Liabilities | 49.9 | 55.4 | 6.9 | 21.8 | 20.4 | 10.9 | 6.3 | 4.6 | 3.2 | 3.2 |
| Total Current Liabilities | 103.9 | 110.9 | 115.2 | 126.6 | 125.8 | 64.3 | 35.6 | 40.6 | 31.4 | 30.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 66.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | (38.9) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 38.9 | 24.0 | 0 | 0 | 0 | 0.0 | 0.2 | 0.3 |
| Total Non-Current Liabilities | 66.8 | 208.2 | 135.6 | 158.0 | 128.4 | 85.0 | 28.8 | 28.8 | 44.3 | 58.4 |
| Total Liabilities | 170.7 | 319.1 | 250.8 | 284.5 | 254.2 | 149.2 | 64.4 | 69.4 | 75.6 | 89.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (2,590.1) | (2,177.4) | (1,658.4) | (1,177.2) | (703.0) | (435.1) | (300.9) | (201.0) | (121.1) | (53.6) |
| Accumulated Other Comprehensive Income | 1.0 | 0.6 | (2.3) | (7.5) | (2.6) | 0.0 | 0.3 | (0.0) | 0 | 0 |
| Total Stockholders' Equity | 671.4 | 872.0 | 1,050.2 | 1,235.6 | 1,040.2 | 527.1 | 269.9 | 277.9 | 300.6 | 209.8 |
| Total Liabilities & Equity | 842.1 | 1,191.0 | 1,301.0 | 1,520.1 | 1,294.5 | 676.3 | 334.3 | 347.3 | 376.2 | 299.0 |
| Debt Metrics | ||||||||||
| Total Debt | 93.3 | 210.2 | 115.3 | 130.7 | 74.0 | 39.3 | 18.4 | 0 | 0 | 0 |
| Net Debt | (62.1) | 21.0 | (111.4) | (392.8) | (49.4) | (120.7) | (38.9) | (58.9) | (340.7) | (273.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (519.0) | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (99.5) | (85.3) | (67.5) | (31.6) |
| Depreciation & Amortization | 10.3 | 10.3 | 9.0 | 7.6 | 6.9 | 6.3 | 5.6 | 4.5 | 3.0 | 1.1 |
| Stock-Based Compensation | 154.3 | 154.3 | 134.1 | 91.4 | 47.0 | 19.9 | 15.1 | 17.0 | 15.3 | 6.7 |
| Change in Working Capital | (73.8) | 11.9 | (52.5) | (53.9) | (22.9) | 57.5 | (20.7) | 3.2 | (16.2) | 59.9 |
| Other Non-Cash Items | 79.3 | (6.3) | (3.5) | 95.8 | 2.9 | 0.6 | (3.7) | (0.6) | 0.2 | 6.7 |
| Operating Cash Flow | (348.9) | (348.9) | (394.1) | (333.3) | (225.0) | (49.9) | (103.2) | (61.3) | (65.3) | 36.1 |
| Investing Activities | ||||||||||
| Capital Expenditure | (5.8) | (5.8) | (14.0) | (58.4) | (12.8) | (3.6) | (6.8) | (6.4) | (10.1) | (6.2) |
| Acquisitions | 0 | 0 | 0 | (44.7) | (3) | 0 | (32.0) | 0.1 | 0 | 0 |
| Purchases of Investments | (935.6) | (935.6) | (904.5) | (429.0) | (1,020.6) | (473.7) | (297.0) | (254.6) | 0 | 0 |
| Sales/Maturities of Investments | 1,046.0 | 1,066.9 | 887.1 | 647.6 | 485.6 | 262.8 | 329 | 0 | 0 | 0 |
| Other Investing Activities | 21.0 | 0 | 0 | 44.8 | 0 | 0 | 32.0 | 0.1 | (0.0) | 0 |
| Investing Cash Flow | 125.6 | 125.6 | (31.3) | 160.3 | (550.8) | (214.5) | 25.2 | (260.8) | (10.1) | (6.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 54.3 | 8.8 | 10.5 | 17.2 | 43.1 | 13.1 | 4.2 | 11.7 | 2.0 | (3.1) |
| Financing Cash Flow | 185.7 | 185.7 | 130.3 | 583.0 | 736.7 | 371.8 | 76.4 | 40.2 | 143.0 | 167.3 |
| Cash Position | ||||||||||
| Net Change in Cash | (37.6) | (37.6) | (295.1) | 410.0 | (39.1) | 107.4 | (1.6) | (281.8) | 67.6 | 197.2 |
| Cash at Beginning | 240.4 | 240.4 | 535.5 | 125.5 | 164.6 | 57.2 | 58.9 | 340.7 | 273.1 | 75.8 |
| Cash at End | 202.8 | 202.8 | 240.4 | 535.5 | 125.5 | 164.6 | 57.2 | 58.9 | 340.7 | 273.1 |
| Free Cash Flow | (354.7) | (354.7) | (408.1) | (391.7) | (237.8) | (53.5) | (110.0) | (67.6) | (75.4) | 29.9 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 67.7 | 57.9 | 36.3 | 52.1 | 33.1 | 58.0 | 43.1 | 30.4 | 26.1 | 16.5 | 6.0 | 0 |
| Gross Profit | 51.7 | 47.6 | 27.3 | 44.5 | 26.2 | (92.4) | (65.3) | (58.7) | (41.5) | (15.4) | (5.1) | (1.7) |
| Operating Income | (441.0) | (534.3) | (515.3) | (458.2) | (267.9) | (136.6) | (106.4) | (90.9) | (69.6) | (32.2) | (13.4) | (5.2) |
| Net Income | (412.7) | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (99.5) | (85.3) | (67.5) | (31.6) | (12.4) | (14.3) |
| EPS (Diluted) | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 | -1.96 | -1.98 | -1.88 | -0.91 | -0.70 | -1.39 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 155.5 | 189.2 | 226.7 | 523.5 | 123.4 | 160.0 | 57.2 | 58.9 | 340.7 | 273.1 | ||
| Total Assets | 842.1 | 1,191.0 | 1,301.0 | 1,520.1 | 1,294.5 | 676.3 | 334.3 | 347.3 | 376.2 | 299.0 | ||
| Total Debt | 93.3 | 210.2 | 115.3 | 130.7 | 74.0 | 39.3 | 18.4 | 0 | 0 | 0 | ||
| Stockholders' Equity | 671.4 | 872.0 | 1,050.2 | 1,235.6 | 1,040.2 | 527.1 | 269.9 | 277.9 | 300.6 | 209.8 | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | (348.9) | (348.9) | (394.1) | (333.3) | (225.0) | (49.9) | (103.2) | (61.3) | (65.3) | 36.1 | ||
| Capital Expenditure | (5.8) | (5.8) | (14.0) | (58.4) | (12.8) | (3.6) | (6.8) | (6.4) | (10.1) | (6.2) | ||
| Free Cash Flow | (354.7) | (354.7) | (408.1) | (391.7) | (237.8) | (53.5) | (110.0) | (67.6) | (75.4) | 29.9 | ||